Michael N. Gwynn
- Molecular Medicine top 0.5%
- Antibiotic Resistance in Bacteria 10
- Pharmacology top 1%
- Microbial Natural Products and Biosynthesis 7
- Microbiology top 2%
- Toxicology top 1%
- Bioactive Compounds and Antitumor Agents 4
-
- Cancer therapeutics and mechanisms 8
- Plant biochemistry and biosynthesis 4
- Microbial Metabolic Engineering and Bioproduction 2
-
- Synthesis and biological activity 2
-
- Bacterial Genetics and Biotechnology 2
- Co-authors
- David PayneDavid HolmesDavid L. PomplianoStephen RittenhouseMartin RosenbergKaren IngrahamB.D. BaxAlexander P. Bryant
- Journals
- Journal of Biological Chemistry (2 papers)Nature Communications (1 paper)Nature Reviews Drug Discovery (1 paper)
- Partner nations
- United StatesUnited KingdomIndia
In The Last Decade
Michael N. Gwynn
22 papers receiving 3.1k citations
Hit Papers
Peers
Comparison fields: 5 of 120
- Molecular Medicine 865
- Pharmacology 880
- Applied Microbiology and Biotechnology 102
- Microbiology 282
- Toxicology 149
Countries citing papers authored by Michael N. Gwynn
This map shows the geographic impact of Michael N. Gwynn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael N. Gwynn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael N. Gwynn more than expected).
Fields of papers citing papers by Michael N. Gwynn
This network shows the impact of papers produced by Michael N. Gwynn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael N. Gwynn. The network helps show where Michael N. Gwynn may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Michael N. Gwynn, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 33 | |
| 2 | 2015 | 16 | |
| 3 | 2015 | 122 | |
| 4 | 2011 | 33 | |
| 5 | 2010 | 24 | |
| 6 | 2010 | 148 | |
| 7 | Structural basis of quinolone inhibition of type IIA topoisomerases and target-mediated resistance. Nat Struct Mol Biol 17(9): 1152-1153 | 2010 | 22 |
| 8 | 2010 | 242 | |
| 9 | 2009 | 5 | |
| 10 | 2008 | 57 | |
| 11 | Drugs for bad bugs: confronting the challenges of antibacterial discoverybreakdown → | 2006 | 1916 |
| 12 | 2005 | 18 | |
| 13 | 2004 | 52 | |
| 14 | 2004 | 39 | |
| 15 | 2003 | 13 | |
| 16 | 2002 | 59 | |
| 17 | 2000 | 67 | |
| 18 | 1990 | 32 | |
| 19 | 1988 | 12 | |
| 20 | 1988 | 10 |
About Michael N. Gwynn
Michael N. Gwynn is a scholar working on Molecular Medicine, Toxicology and Pharmacology, having authored 22 papers that have together received 3.2k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (10 papers), Cancer therapeutics and mechanisms (8 papers), Microbial Natural Products and Biosynthesis (7 papers), Bioactive Compounds and Antitumor Agents (4 papers), Plant biochemistry and biosynthesis (4 papers), Microbial Metabolic Engineering and Bioproduction (2 papers), Synthesis and biological activity (2 papers) and Bacterial Genetics and Biotechnology (2 papers). The work is most often cited by research in Molecular Medicine (865 citations), Pharmacology (880 citations) and Applied Microbiology and Biotechnology (102 citations). Michael N. Gwynn has collaborated with scholars based in United States, United Kingdom and India. Frequent co-authors include David Payne, David Holmes, David L. Pompliano, Stephen Rittenhouse, Martin Rosenberg, Karen Ingraham, B.D. Bax, Alexander P. Bryant, Andrew Fosberry and Paul Homes. Their work appears in journals such as Journal of Biological Chemistry, Nature Communications and Nature Reviews Drug Discovery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.